Enterprise Value
197.6M
Cash
13.52M
Avg Qtr Burn
-11.86M
Short % of Float
0.13%
Insider Ownership
70.35%
Institutional Own.
3.63%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AP-PA02 Details Non-Cystic Fibrosis Bronchiectasis | Phase 2 Data readout | |
AP-SA02 Details Bacterial infection | Phase 2a Data readout | |
AP-PA02 Details Cystic fibrosis | Phase 1/2 Update |